ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,858Medicare Part D Prescriptions Filled, Including Refills

Rank: 71 out of 910

$652K Total Retail Price of All Prescriptions

Rank: 90 out of 910

560 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 560 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

9% of this provider’s 560 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 10,037 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LISINOPRIL 665 567 1 2
LEVOTHYROXINE SODIUM 572 490 2 1
OMEPRAZOLE 358 259 3 5
LOVASTATIN 341 275 4 20
SIMVASTATIN 336 292 5 3
AMLODIPINE BESYLATE 317 269 6 4
METOPROLOL TARTRATE 302 276 7 7
METFORMIN HCL 288 240 8 6
ATENOLOL 231 195 9 10
FUROSEMIDE 218 198 10 9
HYDROCHLOROTHIAZIDE 212 163 11 12
POTASSIUM CHLORIDE 194 159 12 18
WARFARIN SODIUM 193 184 13 11
GABAPENTIN 184 159 14 13
ZOLPIDEM TARTRATE 180 171 15 17
PRAVASTATIN SODIUM 165 160 16 16
TRAMADOL HCL 160 150 17 25
HYDROCODONE-ACETAMINOPHEN 159 131 S3 18 8
FLUTICASONE PROPIONATE 140 128 19 23
ADVAIR DISKUS 139 94 20 45
LOSARTAN POTASSIUM 133 115 21 15
PANTOPRAZOLE SODIUM 131 121 22 27
METOPROLOL SUCCINATE 116 108 23 21
AZITHROMYCIN 102 92 24 41
CIPROFLOXACIN HCL 95 89 25 48
DILTIAZEM ER 95 95 25 105
HYDRALAZINE HCL 93 90 27 65
CLOPIDOGREL 93 93 27 35
ALENDRONATE SODIUM 88 81 29 22
CRESTOR 86 70 30 26
ATORVASTATIN CALCIUM 86 84 30 14
GLIPIZIDE 86 72 30 38
KLOR-CON M20 85 72 33 95
ALLOPURINOL 85 85 33 33
RANITIDINE HCL 81 57 35 28
JANUVIA 79 56 36 69
PROAIR HFA 78 47 37 40
FLUOXETINE HCL 73 56 38 49
SERTRALINE HCL 72 63 39 24
PAROXETINE HCL 70 53 40 50
DOXAZOSIN MESYLATE 65 65 41 62
GLYBURIDE 65 65 R 41 46
NIFEDIPINE ER 64 64 43 107
PREDNISONE 64 34 43 43
NEXIUM 64 52 43 93
DILTIAZEM 24HR ER 62 60 46 244
CLONIDINE HCL 62 59 46 51
DIOVAN 61 57 48 34
ISOSORBIDE MONONITRATE ER 61 60 48 81
VENLAFAXINE HCL ER 61 49 48 115
INSULIN SYRINGE 59 44 51 47
CITALOPRAM HBR 56 45 52 19
PEN NEEDLE 55 37 53 124
LISINOPRIL-HYDROCHLOROTHIAZIDE 55 55 53 44
PROPRANOLOL HCL 54 44 55 120
DONEPEZIL HCL 51 39 56 32
TAMSULOSIN HCL 51 50 56 29
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 30, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.